IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 306 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,900,732 | -16.1% | 85,995 | -24.1% | 0.01% | -11.1% |
| Q2 2023 | $4,649,928 | +25.7% | 113,330 | +9.5% | 0.01% | +28.6% |
| Q1 2023 | $3,698,230 | -48.5% | 103,476 | -45.6% | 0.01% | -53.3% |
| Q4 2022 | $7,187,553 | +76.1% | 190,298 | +106.1% | 0.02% | +66.7% |
| Q3 2022 | $4,081,000 | +11.2% | 92,320 | -7.0% | 0.01% | +28.6% |
| Q2 2022 | $3,671,000 | -65.1% | 99,234 | -65.1% | 0.01% | -61.1% |
| Q1 2022 | $10,521,000 | +78.1% | 284,130 | +46.3% | 0.02% | +100.0% |
| Q4 2021 | $5,906,000 | -24.0% | 194,145 | -16.3% | 0.01% | -30.8% |
| Q3 2021 | $7,773,000 | -12.0% | 231,865 | +4.7% | 0.01% | -13.3% |
| Q2 2021 | $8,835,000 | +537.0% | 221,554 | +616.3% | 0.02% | +650.0% |
| Q1 2021 | $1,387,000 | -62.3% | 30,931 | -52.5% | 0.00% | -71.4% |
| Q4 2020 | $3,678,000 | +4.7% | 65,059 | -12.1% | 0.01% | -12.5% |
| Q3 2020 | $3,512,000 | -26.7% | 74,007 | -9.0% | 0.01% | -27.3% |
| Q2 2020 | $4,794,000 | +63.1% | 81,331 | +31.0% | 0.01% | +37.5% |
| Q1 2020 | $2,939,000 | +120.5% | 62,087 | +180.6% | 0.01% | +300.0% |
| Q4 2019 | $1,333,000 | -1.4% | 22,124 | -2.1% | 0.00% | -33.3% |
| Q3 2019 | $1,352,000 | -12.2% | 22,590 | -5.7% | 0.00% | 0.0% |
| Q2 2019 | $1,540,000 | +18.6% | 23,951 | +49.8% | 0.00% | +50.0% |
| Q1 2019 | $1,298,000 | +97.9% | 15,991 | +31.9% | 0.00% | +100.0% |
| Q4 2018 | $656,000 | +4.8% | 12,128 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $626,000 | +24.0% | 12,128 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $505,000 | -5.6% | 12,128 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $535,000 | -14.3% | 12,128 | -1.4% | 0.00% | 0.0% |
| Q4 2017 | $624,000 | 0.0% | 12,305 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $624,000 | -38.9% | 12,305 | -38.7% | 0.00% | -50.0% |
| Q2 2017 | $1,021,000 | +53.5% | 20,077 | +21.4% | 0.00% | +100.0% |
| Q1 2017 | $665,000 | -31.9% | 16,539 | -17.6% | 0.00% | -50.0% |
| Q4 2016 | $976,000 | – | 20,077 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |